{"id":"cultured-mesenchymal-stem-cells","safety":{"commonSideEffects":[{"rate":null,"effect":"Infusion-related reactions"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Immunological reactions"}]},"_chembl":{"chemblId":"CHEMBL5315110","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into various cell types (osteocytes, chondrocytes, adipocytes) and secrete paracrine factors including anti-inflammatory cytokines and growth factors. These cells modulate immune responses, reduce inflammation, and promote angiogenesis and tissue remodeling at sites of injury or degeneration. The cultured MSC product leverages these properties for therapeutic benefit in degenerative and inflammatory conditions.","oneSentence":"Cultured mesenchymal stem cells promote tissue repair and regeneration through immunomodulation, anti-inflammatory signaling, and differentiation into replacement cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:08:11.326Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Graft-versus-host disease (GVHD)"},{"name":"Tissue repair and regeneration in degenerative conditions"}]},"trialDetails":[{"nctId":"NCT07498218","phase":"PHASE1","title":"Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue","status":"NOT_YET_RECRUITING","sponsor":"Ayu, Inc.","startDate":"2026-03-02","conditions":"Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds","enrollment":24},{"nctId":"NCT06798623","phase":"PHASE1","title":"Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-24","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":15},{"nctId":"NCT07480161","phase":"PHASE2, PHASE3","title":"Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-12-29","conditions":"Erectile Dysfunction With Diabetes Mellitus","enrollment":90},{"nctId":"NCT05651997","phase":"NA","title":"Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the Knee","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2026-12","conditions":"Articular Cartilage Defect, Chondral Defect, Osteochondritis","enrollment":80},{"nctId":"NCT00543374","phase":"PHASE3","title":"Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2007-09-17","conditions":"Crohn's Disease","enrollment":98},{"nctId":"NCT00877903","phase":"PHASE2","title":"Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2009-03-30","conditions":"Myocardial Infarction","enrollment":220},{"nctId":"NCT00683722","phase":"PHASE2","title":"PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-03-20","conditions":"Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, Chronic Bronchitis","enrollment":62},{"nctId":"NCT00482092","phase":"PHASE3","title":"Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2007-09-17","conditions":"Crohn's Disease","enrollment":330},{"nctId":"NCT00690066","phase":"PHASE2","title":"PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-06-11","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent","enrollment":63},{"nctId":"NCT06915233","phase":"PHASE3","title":"A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle","status":"RECRUITING","sponsor":"Vericel Corporation","startDate":"2026-03","conditions":"Chondral Defect, Articular Cartilage Defect","enrollment":309},{"nctId":"NCT04314687","phase":"PHASE1, PHASE2","title":"Stem Cell and Conditioned Medium for Cerebral Palsy","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2021-10-13","conditions":"Cerebral Palsy","enrollment":78},{"nctId":"NCT03158896","phase":"PHASE1","title":"Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-07-09","conditions":"Acute Graft Versus Host Disease","enrollment":24},{"nctId":"NCT07299123","phase":"PHASE1, PHASE2","title":"Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese PLA General Hospital","startDate":"2023-08-01","conditions":"Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia","enrollment":40},{"nctId":"NCT01733186","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects","status":"COMPLETED","sponsor":"Medipost, Inc.","startDate":"2013-01-07","conditions":"Degeneration Articular Cartilage Knee","enrollment":12},{"nctId":"NCT05331872","phase":"PHASE1","title":"Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-01-01","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT04312113","phase":"PHASE1","title":"Angiographic Delivery of AD-MSC for Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2020-11-16","conditions":"Ulcerative Colitis","enrollment":20},{"nctId":"NCT00284986","phase":"PHASE2","title":"Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2005-11-18","conditions":"Graft Versus Host Disease","enrollment":11},{"nctId":"NCT05854641","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Peripheral Arterial Disease","enrollment":10},{"nctId":"NCT05854615","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Buerger's Disease","enrollment":3},{"nctId":"NCT07157891","phase":"EARLY_PHASE1","title":"Investigating the Safety and Regenerative Potential of MSC-Derived Secretome Combined With PRGF in Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"University of the Punjab","startDate":"2025-12-10","conditions":"Osteoarthritis (OA), Knee Injury, Cartilage Degeneration","enrollment":25},{"nctId":"NCT04042844","phase":"PHASE2","title":"A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)","status":"RECRUITING","sponsor":"BioRestorative Therapies","startDate":"2022-06-30","conditions":"Lumbar Disc Disease","enrollment":99},{"nctId":"NCT05027581","phase":"PHASE2","title":"Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)","status":"COMPLETED","sponsor":"Taiwan Bio Therapeutics Inc.","startDate":"2021-10-13","conditions":"Osteoarthritis, Knee","enrollment":72},{"nctId":"NCT05147675","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-12-01","conditions":"Osteoarthritis, Spinal Arthritis","enrollment":92},{"nctId":"NCT06996392","phase":"PHASE1","title":"Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2025-05-07","conditions":"Acute-On-Chronic Liver Failure","enrollment":15},{"nctId":"NCT05158127","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer","status":"NOT_YET_RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-12","conditions":"Skin Ulcer","enrollment":20},{"nctId":"NCT05018845","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2021-11-06","conditions":"Chronic Kidney Diseases","enrollment":20},{"nctId":"NCT05152394","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2024-08-17","conditions":"Parkinson Disease","enrollment":20},{"nctId":"NCT05147688","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2021-12-01","conditions":"Pulmonary Disease, Asthma, Chronic Obstructive Pulmonary Disease","enrollment":20},{"nctId":"NCT05018832","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI","status":"NOT_YET_RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-12","conditions":"Traumatic Brain Injury","enrollment":20},{"nctId":"NCT05147779","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2021-09-12","conditions":"Erectile Dysfunction, Peyronie's Disease, Interstitial Cystitis","enrollment":20},{"nctId":"NCT05152368","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-09-09","conditions":"Peripheral Neuropathy, Trigeminal Neuralgia","enrollment":20},{"nctId":"NCT05016817","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-07-03","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":20},{"nctId":"NCT05158101","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillations for Stroke","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-02-01","conditions":"Stroke","enrollment":15},{"nctId":"NCT05003921","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS","status":"SUSPENDED","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-12","conditions":"Amyotrophic Lateral Sclerosis","enrollment":20},{"nctId":"NCT05018793","phase":"PHASE1","title":"Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2024-12-01","conditions":"Spinal Cord Injuries","enrollment":15},{"nctId":"NCT05147701","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-02-01","conditions":"Eye Diseases, Retinitis Pigmentosa, Diabetic Retinopathy","enrollment":20},{"nctId":"NCT05018871","phase":"PHASE1","title":"Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP","status":"SUSPENDED","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-12","conditions":"Cerebral Palsy","enrollment":15},{"nctId":"NCT05003947","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-06-11","conditions":"Inflammatory Bowel Diseases","enrollment":15},{"nctId":"NCT06143527","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2023-11-16","conditions":"Polycystic Ovary Syndrome (PCOS), Polycystic Ovary Syndrome, PCOS","enrollment":20},{"nctId":"NCT05152290","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-07-06","conditions":"Spinal Cord Injuries","enrollment":20},{"nctId":"NCT05003908","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes","status":"TERMINATED","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2021-11-06","conditions":"Diabetes","enrollment":2},{"nctId":"NCT05003388","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2021-06-26","conditions":"Multiple Sclerosis","enrollment":15},{"nctId":"NCT05152381","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis","status":"WITHDRAWN","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-12-08","conditions":"Osteoporosis","enrollment":""},{"nctId":"NCT05003960","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-01-23","conditions":"Autism","enrollment":15},{"nctId":"NCT05016804","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-07-04","conditions":"Systemic Sclerosis","enrollment":20},{"nctId":"NCT05003934","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2021-11-07","conditions":"Rheumatoid Arthritis","enrollment":20},{"nctId":"NCT05018819","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-02-01","conditions":"Cerebral Palsy","enrollment":15},{"nctId":"NCT05018858","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-12","conditions":"Lupus","enrollment":15},{"nctId":"NCT05158933","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure","status":"WITHDRAWN","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-04-03","conditions":"Ovarian Failure","enrollment":""},{"nctId":"NCT05147766","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease","status":"TERMINATED","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-02-01","conditions":"Congestive Heart Failure, Angina","enrollment":3},{"nctId":"NCT05158114","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia","status":"WITHDRAWN","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-04-03","conditions":"Testicular Injury, Oligospermia","enrollment":""},{"nctId":"NCT05018767","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-01-22","conditions":"Frailty","enrollment":86},{"nctId":"NCT06896747","phase":"PHASE1, PHASE2","title":"Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-02-21","conditions":"Thin Endometrial Lining, Female Infertility, Intrauterine Adhesions","enrollment":90},{"nctId":"NCT04410731","phase":"PHASE1","title":"Allogeneic BM-MSCs in Patients with Lumbar Facet Arthropathy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-04-28","conditions":"Facet-Mediated Low Back Pain","enrollment":10},{"nctId":"NCT06078059","phase":"NA","title":"Mechanisms of Treatment Effects Using Cultured, Allogeneic Mesenchymal Stromal Stem Cells (MSCs) in Knee Osteoarthritis","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2022-11-01","conditions":"Osteoarthritis, Knee","enrollment":30},{"nctId":"NCT03325504","phase":"PHASE3","title":"A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union","status":"COMPLETED","sponsor":"Universidad Autonoma de Madrid","startDate":"2017-09-05","conditions":"Non Union Fracture","enrollment":46},{"nctId":"NCT06505941","phase":"PHASE1, PHASE2","title":"Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS","status":"NOT_YET_RECRUITING","sponsor":"Southeast University, China","startDate":"2024-07-20","conditions":"Acute Respiratory Distress Syndrome","enrollment":60},{"nctId":"NCT05345418","phase":"PHASE1, PHASE2","title":"Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency","status":"RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2022-04-01","conditions":"Sexual Dysfunction Male","enrollment":158},{"nctId":"NCT06231771","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer","status":"NOT_YET_RECRUITING","sponsor":"Supergenics Life Science Sdn. Bhd.","startDate":"2024-05","conditions":"Diabetic Foot Ulcer","enrollment":22},{"nctId":"NCT03969680","phase":"NA","title":"Mesenchymal Stem Cell Transplantation for Osteoarthritis","status":"TERMINATED","sponsor":"Yantai Yuhuangding Hospital","startDate":"2019-07-08","conditions":"Knee Osteoarthritis","enrollment":2},{"nctId":"NCT03631420","phase":"PHASE1","title":"Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants","status":"RECRUITING","sponsor":"Meridigen Biotech Co., Ltd.","startDate":"2018-10-26","conditions":"Bronchopulmonary Dysplasia","enrollment":9},{"nctId":"NCT04744051","phase":"PHASE1","title":"ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion","status":"UNKNOWN","sponsor":"American CryoStem Corporation","startDate":"2021-02-01","conditions":"Post-Concussion Syndrome","enrollment":20},{"nctId":"NCT05850208","phase":"PHASE1","title":"Autologous Bone Marrow Mesenchymal Stem Cells (BMSCs) Transplantation in the Treatment of Ischemic Stroke","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2022-02-23","conditions":"Ischemic Stroke","enrollment":60},{"nctId":"NCT03968198","phase":"PHASE2","title":"Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia.","status":"TERMINATED","sponsor":"University Hospital, Toulouse","startDate":"2020-03-04","conditions":"Critical Limb Ischemia and Peripheral Artery Disease","enrollment":2},{"nctId":"NCT02462330","phase":"PHASE2","title":"Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2016-02-19","conditions":"Chronic Myocardial Ischemia","enrollment":39},{"nctId":"NCT04212728","phase":"NA","title":"Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells","status":"UNKNOWN","sponsor":"Yantai Yuhuangding Hospital","startDate":"2019-12-29","conditions":"Knee Osteoarthritis","enrollment":60},{"nctId":"NCT02025270","phase":"PHASE1, PHASE2","title":"MSCs For Treatment of Azoospermic Patients","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2012-10-15","conditions":"Male Infertility","enrollment":100},{"nctId":"NCT04340609","phase":"PHASE1, PHASE2","title":"Stem Cell in Acute Myocardial Infarction","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2019-03-11","conditions":"Acute Myocardial Infarction","enrollment":4},{"nctId":"NCT02497443","phase":"PHASE1, PHASE2","title":"Safety of Autologous MSC Infusion to Treat Epilepsy","status":"COMPLETED","sponsor":"Ministry of Public Health, Republic of Belarus","startDate":"2011-04","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT05158439","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome","status":"WITHDRAWN","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-01","conditions":"Tourette Syndrome","enrollment":""},{"nctId":"NCT00366145","phase":"PHASE3","title":"Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2006-08-17","conditions":"Graft Versus Host Disease","enrollment":260},{"nctId":"NCT00136903","phase":"PHASE2","title":"Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2005-04-27","conditions":"Graft Vs Host Disease","enrollment":32},{"nctId":"NCT00702741","phase":"PHASE1, PHASE2","title":"Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy","status":"COMPLETED","sponsor":"Mesoblast International Sàrl","startDate":"2008-06","conditions":"Recovery Following Partial Medial Meniscectomy","enrollment":55},{"nctId":"NCT02065167","phase":"PHASE2","title":"Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip","status":"COMPLETED","sponsor":"Universidad Autonoma de Madrid","startDate":"2014-02","conditions":"Avascular Necrosis of the Femoral Head","enrollment":26},{"nctId":"NCT02336646","phase":"PHASE1","title":"Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease","status":"COMPLETED","sponsor":"Taiwan Bio Therapeutics Inc.","startDate":"2015-05-01","conditions":"Critical Limb Ischemia","enrollment":18},{"nctId":"NCT04876326","phase":"NA","title":"Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2020-10-05","conditions":"Multiple System Atrophy, Parkinsonism, Multiple System Atrophy, Parkinson Variant","enrollment":15},{"nctId":"NCT04763369","phase":"PHASE2","title":"Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP)","status":"UNKNOWN","sponsor":"Jinnah Burn and Reconstructive Surgery Centre, Lahore","startDate":"2021-02","conditions":"Retinitis Pigmentosa (RP)","enrollment":50},{"nctId":"NCT03371329","phase":"PHASE1","title":"Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-12-12","conditions":"Hemorrhagic Stroke, Intracerebral Hemorrhage","enrollment":9},{"nctId":"NCT03855631","phase":"","title":"Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2020-09-28","conditions":"Kabuki Syndrome 1","enrollment":8},{"nctId":"NCT02566655","phase":"PHASE1","title":"Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis","status":"COMPLETED","sponsor":"Red de Terapia Celular","startDate":"2015-09","conditions":"Osteoporosis, Spinal Fractures","enrollment":10},{"nctId":"NCT00294112","phase":"PHASE2","title":"Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2006-03-13","conditions":"Crohn's Disease","enrollment":10},{"nctId":"NCT04313322","phase":"PHASE1","title":"Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells","status":"UNKNOWN","sponsor":"Stem Cells Arabia","startDate":"2020-03-16","conditions":"Use of Stem Cells for COVID-19 Treatment","enrollment":5},{"nctId":"NCT00114452","phase":"PHASE1","title":"Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2005-03-22","conditions":"Myocardial Infarction","enrollment":60},{"nctId":"NCT00759018","phase":"","title":"Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD","status":"NO_LONGER_AVAILABLE","sponsor":"Mesoblast, Inc.","startDate":"","conditions":"Graft vs Host Disease, Graft-Versus-Host Disease","enrollment":""},{"nctId":"NCT00826046","phase":"","title":"Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD)","status":"NO_LONGER_AVAILABLE","sponsor":"Mesoblast, Inc.","startDate":"","conditions":"Graft-Versus-Host Disease","enrollment":""},{"nctId":"NCT03003364","phase":"PHASE1, PHASE2","title":"Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury","status":"COMPLETED","sponsor":"Banc de Sang i Teixits","startDate":"2016-12-27","conditions":"Spinal Cord Injury, Chronic","enrollment":10},{"nctId":"NCT02166021","phase":"PHASE2","title":"Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Dimitrios Karussis","startDate":"2015-01-29","conditions":"Multiple Sclerosis (MS)","enrollment":48},{"nctId":"NCT03066245","phase":"PHASE1, PHASE2","title":"Use of Stem Cells Cultured on a Scaffold for the Treatment of Aneurysmal Bone Cysts (ABC)","status":"UNKNOWN","sponsor":"Sophia Al-Adwan","startDate":"2018-05-03","conditions":"Aneurysmal Bone Cyst","enrollment":4},{"nctId":"NCT01051882","phase":"PHASE1, PHASE2","title":"Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.","status":"COMPLETED","sponsor":"Brainstorm-Cell Therapeutics","startDate":"2011-06","conditions":"Amyotrophic Lateral Sclerosis","enrollment":12},{"nctId":"NCT03638154","phase":"NA","title":"Regenerative Potential of Cultured Gingival Fibroblast- Mesenchymal Stem Cells in Treatment of Periodontitis","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2016-03-15","conditions":"Periodontal Intrabony Defect","enrollment":20},{"nctId":"NCT02824393","phase":"EARLY_PHASE1","title":"Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria","status":"COMPLETED","sponsor":"Celal Bayar University","startDate":"2017-03-03","conditions":"Urticaria, Autoimmune Diseases, Immune System Diseases","enrollment":10},{"nctId":"NCT02387749","phase":"NA","title":"Effect Of Mesenchymal Stem Cells Transfusion on the Diabetic Peripheral Neuropathy Patients .","status":"COMPLETED","sponsor":"Cairo University","startDate":"2014-05","conditions":"Diabetic Peripheral Neuropathy","enrollment":10},{"nctId":"NCT03563495","phase":"NA","title":"Tissue Engineered Constructs for Alveolar Cleft Repair","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-02","conditions":"Cleft Lip and Palate","enrollment":10},{"nctId":"NCT03529136","phase":"PHASE2","title":"Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis","status":"UNKNOWN","sponsor":"Shandong Qilu Stem Cells Engineering Co., Ltd.","startDate":"2018-06-01","conditions":"Decompensated Liver Cirrhosis","enrollment":252},{"nctId":"NCT01849159","phase":"PHASE1, PHASE2","title":"Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema","status":"WITHDRAWN","sponsor":"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia","startDate":"2014-03","conditions":"Pulmonary Emphysema","enrollment":""},{"nctId":"NCT02460770","phase":"PHASE1","title":"Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device","status":"WITHDRAWN","sponsor":"University Hospital, Toulouse","startDate":"2015-06","conditions":"Chronic Myocardial Ischemia","enrollment":""},{"nctId":"NCT03103295","phase":"PHASE1, PHASE2","title":"3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects","status":"UNKNOWN","sponsor":"A.A. Partners, LLC","startDate":"2015-11-20","conditions":"Bone Defects","enrollment":20},{"nctId":"NCT03113747","phase":"PHASE1, PHASE2","title":"Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs)","status":"UNKNOWN","sponsor":"A.A. Partners, LLC","startDate":"2015-03-25","conditions":"Second- or Third-degree Burns","enrollment":20},{"nctId":"NCT01716481","phase":"PHASE3","title":"The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2012-11","conditions":"Stroke, Ischemic","enrollment":60},{"nctId":"NCT03056742","phase":"PHASE2","title":"A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease","status":"WITHDRAWN","sponsor":"Stempeutics Research Pvt Ltd","startDate":"2017-02-20","conditions":"Critical Limb Ischemia Due to Buerger's Disease","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":133,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Cultured Mesenchymal Stem Cells","genericName":"Cultured Mesenchymal Stem Cells","companyName":"Universidad Autonoma de Madrid","companyId":"universidad-autonoma-de-madrid","modality":"Biologic","firstApprovalDate":"","aiSummary":"Cultured mesenchymal stem cells promote tissue repair and regeneration through immunomodulation, anti-inflammatory signaling, and differentiation into replacement cells. Used for Graft-versus-host disease (GVHD), Tissue repair and regeneration in degenerative conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}